Registration from the meeting of the working group of MZ SR, responsible for the analysis of reporting of consumption of drugs in Slovakia in OECD statistics, on 23.11.2016 at 09.30 am. on MZ SR

For MZ SR:

Peter Mrva, representing director of OKCLP
Michal Štofko, Director of the OS
Erika Hanzely, OKCLP Official

For NCZI:

Martina Nagy
Martina Vrbiková
Zuzana Vallová

For the GPP:

Lubica Hlinka
Lyudmila Krč-Only

For the AIFP:

Katarína Slezáková
Petra Szilágyi
Miroslav Dedík

Under the authority of State Secretary Doc. MUDr. Andrei Kalavskaya, PhD., MHA was established working group of MZ SR responsible for analysis reporting the consumption of medicines in Slovakia to OECD statistics. At the same time, the task of working the group is also proposing measures to achieve correct reporting.

The meeting was opened by the Deputy Director of the Division categorisation, pricing and drug policy of MVDr. Mgr. Peter Mrva, MPH.

Programme

1. In its presentation, the representative of the AIFM stated the reason why has Slovakia in reporting the consumption of medicinal products for a defined daily dose (per
1,000 population per day) for the OECD higher consumption than in fact. The reason is, that the OECD reports the consumption of medicinal products on the basis of the current defined daily dose Slovakia reports consumption based on the standard dose of the drug . (SDL).

2. Since no public information is currently available the total expenditure on medicinal products, it is necessary to lay down rules on reporting and consequently it would be good to report this expenditure to the OECD.

3. The current method of data collection is as follows:
SUKL has import data from authorisation holders for large distribution. This data is processed by the company MCR s.r.o. that delivers NCZI report. NCZI does not control this data, only sends the data processed in this way to OECD.

4. Reporting of drug expenditure and reporting of expenditure medicines as a proportion of all healthcare expenditure within The Statistical Office is responsible for health accounts.

Tasks

1. NCZI will review the methodology for reporting on the consumption of medicinal products such as OECD and the options for calculating this indicator from data currently available to NCZI. NCZI identifies the requirements for the delivery of information sources for development the converter between DDD and SDL. On the basis of this information, a further Procedure. The NCAI assumes that this information will be processed by 05.12.2016.

2. Ministry requests ŠUKL for a reporting methodology use of medicines.

3. The Ministry will address the Statistical Office and ask for it transmission of a methodology for reporting total expenditure on medicinal products within the meaning of "Memorandum".

4. The text -Memoranda-.

5. Representatives will also be invited to the next meeting State Medicine Control Institute.